* Miromatrix Medical Inc MIRO.OQ reported a quarterly adjusted
loss of $1.27 per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of 25 cents
per share.
* Revenue was $9.00 thousand; analysts expected zero.
* Miromatrix Medical Inc's reported EPS for the quarter was a
loss of $1.27.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Miromatrix Medical Inc shares had risen by 3.0% this quarter.
* The company reported a quarterly loss of $3.7 million.
* Wall Street's median 12-month price target for Miromatrix
Medical Inc is $22.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated August 12 at 10:38 p.m. All
figures in US dollars unless otherwise stated